Onpattro 10 MG/5 ML vial 5ML
Ended Awarded
- Contract number
- SPE2DX25F6ADK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $14,187
Award facts
- Contract value 100% obligated
- $14,186.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $14,186.86 on August 18, 2025, for the supply of Onpattro (patisiran) 10 mg/5 ml vials. The contract, which carries no set-aside designation, is set to be completed by September 9, 2025, with performance taking place at the vendor's Park Ridge, Illinois facility. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, a $499.99 billion contract vehicle through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products to support military healthcare facilities worldwide.
The funding source is the Defense Logistics Agency's Medical Supply Chain, reflecting the Department of Defense's continued reliance on DMS Pharmaceutical Group as a critical supplier within the federal pharmaceutical distribution network. Onpattro is a specialty pharmaceutical used in treating hereditary transthyretin amyloidosis, underscoring the contract's focus on providing advanced therapeutic medications to military and federal healthcare systems. DMS Pharmaceutical Group's consistent track record of securing delivery orders for specialty pharmaceuticals, biologics, and medical consumables demonstrates its established position as a key vendor supporting the Defense Department's medical supply requirements.
Quick answers
Who was awarded contract SPE2DX25F6ADK?
SPE2DX25F6ADK was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 18, 2025.
How much is contract SPE2DX25F6ADK worth?
The government has obligated $14,187 on SPE2DX25F6ADK.
Is contract SPE2DX25F6ADK an order under another contract?
Yes. SPE2DX25F6ADK is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6ADK competed?
The extent of competition for SPE2DX25F6ADK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award